Alzheimer’s Disease Pharmacotherapy, Biomarkers and Genetics

Abstract

This Alzheimer 's disease review has a focus on historical, statistical, financial, and genetic disease factors. Genetic research, particularly the TOMMOROW study, as well as its theoretical bases, is reviewed. Select cognitive and adjunctive pharmacotherapies that are currently prescribed in these dementia patients are discussed. Both the inherited and sporadic types are reviewed, as well as the theoretical basis for current treatment of Alzheimer's disease. Prevalence, both current and projected, is also discussed. Bio-markers identified as useful in the detection of Alzheimer's dementia and their potential usefulness in earlier intervention are also covered in this review.